About Nutron Pharmaceuticals Private Limited
Data last updated:
Nutron Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 12 October 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1990PTC058515. Its GSTIN is 27AAACN9128K1Z5 (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹4.83 Lakh. It is led by directors including Ritesh Ramesh Shah and Praful Ramesh Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 401 Earth Sampann Bldg 198/200 Khetwadi Main Road 4th Floor, Mumbai, Maharashtra, India – 400004.
As per the financials filed for FY 2025, the company reported a revenue of ₹51.48 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net profit of ₹5.42 Cr (net margin 10.5%) and EBITDA of ₹6.89 Cr (EBITDA margin 13.4%). Revenue has declined at a compounded annual rate (CAGR) of 20% over three years and 2% over five years.
As per MCA filings, the company has open charges of ₹15 Cr and satisfied charges of ₹26.94 Cr on record. Court records list 6 cases involving the company, including 5 filed by the company; 1 case is pending. The company has 1 deal on record (1 secondary share transfer); the latest was in March 2011. Its 10 peer companies in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals) are compared by revenue, 5 larger and 5 smaller; the largest is Siddhika Coatings Limited with revenue of ₹51.78 Cr. The company has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 42 overdue payments to 12 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nutron.lookchem.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered Address401 Earth Sampann Bldg 198/200 Khetwadi Main Road 4th Floor, Mumbai, Maharashtra, India – 400004
- IndustryChemicals and Materials, Chemical Distribution & Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Nutron Pharmaceuticals Private Limited
The main business activity of Nutron Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Nutron Pharmaceuticals Private Limited FY 2025 filings available
Nutron Pharmaceuticals Private Limited reported revenue of ₹51.48 Cr (up 1% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Nutron Pharmaceuticals Private Limited
Revenue rose 1% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 2%. EBITDA rose 32% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Nutron Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹6.89 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹5.42 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Nutron Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 10.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Nutron Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Siddhika Coatings Limited | ₹51.78 Cr (FY 2025) | •••• | •••• | 32.0% | •••• | New Delhi, Delhi, India |
| Vatika Distributors Private Limited | ₹51.65 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Kolkata, West Bengal, India |
| Venus Chemcorp Private Limited | ₹51.56 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Mumbai, Maharashtra, India |
| Metrix Healthcare Private Limited | ₹51.51 Cr (FY 2017) | •••• | •••• | 31.0% | •••• | Ahmedabad, Gujarat, India |
| Toyo Ink Arets India Private Limited | ₹51.49 Cr (FY 2024) | •••• | •••• | 11.0% | •••• | New Delhi, Delhi, India |
| Nutron Pharmaceuticals Private Limited this company | ₹51.48 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| K. A. Malle Pharmaceuticals Limited | ₹51.47 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Mumbai, Maharashtra, India |
| KGN Pharmaceuticals Private Limited | ₹51.45 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Mumbai, Maharashtra, India |
| Sanchay Vanijya Rasayan Private Limited | ₹51.44 Cr (FY 2024) | •••• | •••• | -6.0% | •••• | Delhi, India |
| Yashika Petrochem Private Limited | ₹51.39 Cr (FY 2025) | •••• | •••• | 25031202.0% | •••• | Delhi, India |
| Sol Derma Pharmaceuticals Private Limited | ₹51.29 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Ahmedabad, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Nutron Pharmaceuticals by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals Private Limited is audited by V. C. SHAH & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| V. C. SHAH & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals has 7 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ritesh Ramesh Shah Also directs: Mehal Enterprise LLP, Terrapolis Buildcon Private Limited, New Dholera Shipping & Trading Co Limited and 1 more | Director | 18 Oct 2012 | 13 Years 11 Months | Current |
| Praful Ramesh Shah | Director | 18 Oct 2012 | 13 Years 11 Months | Current |
| Popatlal Hanjarimal Shah | Director | 12 Oct 1990 | 36 Years 0 Months | Current |
| Jayesh Popatlal Shah Also directs: Mehal Enterprise LLP, Terrapolis Buildcon Private Limited | Director | 15 Mar 1999 | 27 Years 6 Months | Current |
| Ramesh Hanjarimal Shah Also directs: Mehal Enterprise LLP | Director | 12 Oct 1990 | 36 Years 0 Months | Current |
| Manish Bhuralal Shah Also directs: Mehal Enterprise LLP, Terrapolis Buildcon Private Limited | Director | 03 Apr 1995 | 31 Years 6 Months | Current |
Ownership and Shareholding of Nutron Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Nutron Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Jan 2021 | Others | ₹15 Cr | Open |
| 15 Feb 2008 | Citi Bank N.A. | ₹22.5 Cr | Satisfied |
| 05 Mar 2007 | Citibank N.A. | ₹2.5 Cr | Satisfied |
| 17 Sep 2003 | The Sangli Bank Limited | ₹1.5 Cr | Satisfied |
| 28 Jul 1998 | Bank of Madura Ltf | ₹9.33 Lakh | Satisfied |
Total charge records: 7 View all charges
Deals & Funding of Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2011.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
Full deal history
All 1 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals Private Limited has 6 court cases on record: 5 filed by Nutron Pharmaceuticals, 1 where it is another party. 1 case is pending and 5 are disposed. Status as checked between 21 Sep 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 0 | 1 |
| High courts | 2 | 0 | 0 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed by the company against Sv's Remedies Limited | Disposed |
| District court, Mumbai City Civil Court, Maharashtra | Commercial matter | Filed by the company against an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (S S) | Filed by the company against an individual | Disposed |
| Bombay High Court | Company petition | Company is another party | Disposed |
| Bombay High Court | Company petition | Filed by the company against Dujodwala Papers Chemicals Ltd | Disposed |
Full case history
All 6 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2023, listing 42 overdue payments to 12 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 12)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Relic Chemicals | •••• | •••• | •••• |
| R R Innovative P Ltd | •••• | •••• | •••• |
| Gurudev Dye-Chem Private Limited | •••• | •••• | •••• |
| Sanjay Chemicals (India) Private Limited | •••• | •••• | •••• |
| Sparchem | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 2 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Nutron Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Nutron Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals Private Limited has 9 board changes on record since 1990: 7 appointments and 2 cessations. The latest: Praful Ramesh Shah ceased to be Additional Director on 24 Sep 2013.
16 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Nutron Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Nutron Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACN9128K1Z5 | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Nutron Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nutron Pharmaceuticals Private Limited
Nutron Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 12 October 1990 (36+ years old) and is registered under CIN U24230MH1990PTC058515.
Nutron Pharmaceuticals reported revenue of ₹51.48 Cr for FY 2025 (up 1% YoY).
Nutron Pharmaceuticals has 7 current directors:
- Ritesh Ramesh Shah - Director
- Praful Ramesh Shah - Director
- Popatlal Hanjarimal Shah - Director
- Jayesh Popatlal Shah - Director
- Ramesh Hanjarimal Shah - Director
- Manish Bhuralal Shah - Director
- Dinesh Popatlal Shah - Director
Nutron Pharmaceuticals reported a net profit of ₹5.42 Cr (net margin 10.5%) and EBITDA of ₹6.89 Cr (EBITDA margin 13.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Nutron Pharmaceuticals is -20% over three years and -2% over five years. In the latest year (FY 2025) revenue rose 1%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Nutron Pharmaceuticals is 27AAACN9128K1Z5, registered in Maharashtra.
The CIN (Corporate Identification Number) of Nutron Pharmaceuticals is U24230MH1990PTC058515. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nutron Pharmaceuticals has 6 court cases on record: 5 filed by the company. 1 is pending. Most are in the district courts.
Nutron Pharmaceuticals was incorporated on 12 October 1990, making it 36+ years old. It is registered with the Registrar of Companies, Mumbai.
Nutron Pharmaceuticals has 1 deal on record (1 secondary share transfer); the latest was in March 2011.
The peers of Nutron Pharmaceuticals by revenue are Siddhika Coatings Limited, Vatika Distributors Private Limited, Venus Chemcorp Private Limited, Metrix Healthcare Private Limited, Toyo Ink Arets India Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals).
Praful Ramesh Shah ceased to be Additional Director on 24 Sep 2013. Ritesh Ramesh Shah ceased to be Additional Director on 24 Sep 2013. Praful Ramesh Shah was appointed as Director on 18 Oct 2012. Nutron Pharmaceuticals has 9 board changes on record in total.